Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

1.2100 0.0000 (0.00%) At close: 02:22PM EDT

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 48,164

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Qiuhua Yang	Executive Chairman	N/A	N/A	1972
Mr. Bo Shen	President, CFO, Head of the Accounting Department & Executive Director	778.9k	N/A	1973
Mr. Yongzhong Li	VP & Executive Director	832.63k	N/A	1970
Mr. Ming Dong	Executive Director	N/A	N/A	1976
Mr. Tao Zhong	VP, Board Secretary & Joint Company Secretary	N/A	N/A	1972
Mr. Dongming Li	Vice President	N/A	N/A	1969
Ms. Shuai Shao	Vice President	N/A	N/A	1988
Dr. Shunjiang Yu	Chief Medical Officer	N/A	N/A	N/A
Ms. Pui Kiu Wong	Joint Company Secretary	N/A	N/A	N/A
Ying Ke	Director & General Manager of R&D Management Center	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Corporate governance

Shanghai Pharmaceuticals Holding Co., Ltd’s ISS governance QualityScore as of 29 April 2024 is 7. The pillar scores are Audit: 7; Board: 9; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.